JENNA DAVIS: Open Payments
NPI 1629808670 · NEWPORT, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$413 in 21 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $57 · 2025 $413
Food & beverage: $413
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $82 |
| Novo Nordisk Inc | 3 | $58 |
| Lilly USA, LLC | 3 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Axsome Therapeutics, Inc. | 1 | $41 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| Eisai Inc. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Sage Therapeutics, LLC | 1 | $19 |
| Exact Sciences Corporation | 1 | $17 |
Products named: VRAYLAR, CAPLYTA, Auvelity, TRELEGY ELLIPTA, Wegovy, MOUNJARO, Ozempic, QULIPTA.
Industry payments across KY — which companies pay providers there.
